BE667333A - - Google Patents

Info

Publication number
BE667333A
BE667333A BE667333A BE667333A BE667333A BE 667333 A BE667333 A BE 667333A BE 667333 A BE667333 A BE 667333A BE 667333 A BE667333 A BE 667333A BE 667333 A BE667333 A BE 667333A
Authority
BE
Belgium
Application number
BE667333A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of BE667333A publication Critical patent/BE667333A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D235/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • C07D235/10Radicals substituted by halogen atoms or nitro radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D235/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • C07D235/12Radicals substituted by oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D235/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • C07D235/14Radicals substituted by nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
BE667333A 1964-07-23 1965-07-23 BE667333A (en:Method)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DESC035513 1964-07-23
DESC037200 1965-06-10
DESC037199 1965-06-10

Publications (1)

Publication Number Publication Date
BE667333A true BE667333A (en:Method) 1966-01-24

Family

ID=27212324

Family Applications (1)

Application Number Title Priority Date Filing Date
BE667333A BE667333A (en:Method) 1964-07-23 1965-07-23

Country Status (12)

Country Link
US (1) US3423413A (en:Method)
BE (1) BE667333A (en:Method)
BR (1) BR6571550D0 (en:Method)
CH (1) CH494229A (en:Method)
DE (2) DE1620450C3 (en:Method)
DK (1) DK121376B (en:Method)
ES (1) ES315729A1 (en:Method)
GB (1) GB1115390A (en:Method)
IL (1) IL24007A (en:Method)
NL (1) NL143569B (en:Method)
NO (1) NO122124B (en:Method)
SE (1) SE339228B (en:Method)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4946843A (en) * 1987-07-10 1990-08-07 Janssen Pharmaceutica N.V. 2-(heterocyclylalkyl)imidazopyridines

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3531485A (en) * 1967-08-14 1970-09-29 American Home Prod Aryl-substituted diazabicycloalkanes
DE2436883C2 (de) * 1974-07-29 1985-08-22 Schering AG, 1000 Berlin und 4709 Bergkamen Benzimidazol-Derivate, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
US4404382A (en) * 1980-09-17 1983-09-13 The Upjohn Company Piperazinyl-substituted imidazoles
DE3132916A1 (de) * 1981-08-20 1983-03-03 Kali-Chemie Pharma Gmbh, 3000 Hannover 1-phenylindazol-3-on-verbindungen sowie verfahren und zwischenprodukte zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
JPS5879983A (ja) 1981-11-06 1983-05-13 Kanebo Ltd 新規なベンズイミダゾ−ル誘導体、その製造法およびその医薬組成物
JPS59199679A (ja) * 1983-04-27 1984-11-12 Kanebo Ltd 新規なベンズイミダゾ−ル誘導体、その製造法およびその医薬組成物
HUP0301550A2 (hu) * 2000-10-31 2003-09-29 Basf Aktiengesellschaft Hiper-elágazó poliuretánok alkalmazása nyomdafestékek elżállítására
WO2003060475A2 (en) 2002-01-10 2003-07-24 Neurogen Corporation Melanin concentrating hormone receptor ligands: substituted 2-(4-benzyl-piperazin-1-ylmethyl)- and 2-(4-benzyl-diazepan-1-ylmethyl)-1h-benzoimidazole analogues
EP1465888A2 (en) 2002-01-10 2004-10-13 Neurogen Corporation Melanin concentrating hormone receptor ligands: substituted benzoimidazole analogues
US8895598B2 (en) * 2007-09-18 2014-11-25 The Board Of Trustees Of The Leland Stanford Junior University Methods of treating a flaviviridae family viral infection, compositions for treating a flaviviridae family viral infection, and screening assays for identifying compositions for treating a flaviviridae family viral infection
US8940730B2 (en) 2007-09-18 2015-01-27 The Board Of Trustees Of The Leland Stanford Junior University Methods and compositions of treating a Flaviviridae family viral infection
US9101628B2 (en) * 2007-09-18 2015-08-11 The Board Of Trustees Of The Leland Stanford Junior University Methods and composition of treating a flaviviridae family viral infection
JP2012520884A (ja) * 2009-03-18 2012-09-10 ザ ボード オブ トラスティーズ オブ ザ リランド スタンフォード ジュニア ユニバーシティー フラビウイルス科ウイルス感染症を治療する方法および組成物

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL302847A (en:Method) * 1963-01-10

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4946843A (en) * 1987-07-10 1990-08-07 Janssen Pharmaceutica N.V. 2-(heterocyclylalkyl)imidazopyridines
US5011842A (en) * 1987-07-10 1991-04-30 Janssen Pharmaceutica N.V. 2-(heterocyclylalkyl)imidazopyridines for treating allergic diseases
US5086056A (en) * 1987-07-10 1992-02-04 Janssen Pharmaceutica N.V. 2-(heterocyclylalkyl)imidazopyridines

Also Published As

Publication number Publication date
NL6509573A (en:Method) 1966-01-24
NO122124B (en:Method) 1971-05-24
US3423413A (en) 1969-01-21
IL24007A (en) 1969-06-25
BR6571550D0 (pt) 1973-08-14
CH494229A (de) 1970-07-31
DK121376B (da) 1971-10-11
DE1620449B2 (de) 1973-07-26
GB1115390A (en) 1968-05-29
DE1470319B2 (de) 1975-09-18
DE1620449A1 (de) 1970-04-30
DE1620449C3 (de) 1974-02-21
NL143569B (nl) 1974-10-15
ES315729A1 (es) 1966-02-16
DE1620450C3 (de) 1976-01-02
DE1470319A1 (de) 1969-10-02
DE1620450A1 (de) 1970-02-19
SE339228B (en:Method) 1971-10-04
DE1620450B2 (de) 1975-05-22

Similar Documents

Publication Publication Date Title
BE648757A (en:Method)
BE642589A (en:Method)
BE636791A (en:Method)
BE637950A (en:Method)
BE659204A (en:Method)
BE659111A (en:Method)
BE658591A (en:Method)
BE658524A (en:Method)
BE658385A (en:Method)
BE658147A (en:Method)
BE653458A (en:Method)
BE651803A (en:Method)
BE642104A (en:Method)
BE646329A (en:Method)
NL6509573A (en:Method)
BE645391A (en:Method)
BE642974A (en:Method)
BE642797A (en:Method)
BE642770A (en:Method)
BE642741A (en:Method)
BE642735A (en:Method)
BE642654A (en:Method)
BE642652A (en:Method)
BE659949A (en:Method)
BE637777A (en:Method)